These new cases extend the β-III spectrin-associated phenotypes, and establish that heterozygous SPTBN2 mutations can lead to NPCA with evidence of neurodegeneration on neuroimaging. This evidence concerns the gene SPTBN2 and nasopharyngeal carcinoma, susceptibility to, 1.